184 related articles for article (PubMed ID: 33601141)
1. Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives.
Gao XZ; Lv XT; Zhang RR; Luo Y; Wang MX; Chen JS; Zhang YK; Sun B; Sun JY; Liu YF; Liu C
Bioorg Chem; 2021 Apr; 109():104694. PubMed ID: 33601141
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and in vitro evaluation of fangchinoline derivatives as potential anticancer agents.
Zhang YC; Gao XZ; Liu C; Wang MX; Zhang RR; Sun JY; Liu YF
Bioorg Chem; 2020 Jan; 94():103431. PubMed ID: 31759658
[TBL] [Abstract][Full Text] [Related]
3. Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer.
Chen JS; Guo X; Sun JY; Wang MX; Gao XZ; Wang Z; Han JL; Sun H; Zhang K; Liu C
Bioorg Chem; 2023 Sep; 138():106623. PubMed ID: 37295240
[TBL] [Abstract][Full Text] [Related]
4. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway.
Yang J; Hu S; Wang C; Song J; Chen C; Fan Y; Ben-David Y; Pan W
Eur J Med Chem; 2020 Jan; 186():111898. PubMed ID: 31784186
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents.
Li D; Liu H; Liu Y; Zhang Q; Liu C; Zhao S; Jiao B
Bioorg Med Chem Lett; 2017 Feb; 27(3):533-536. PubMed ID: 28057423
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel C
Lan J; Huang L; Lou H; Chen C; Liu T; Hu S; Yao Y; Song J; Luo J; Liu Y; Xia B; Xia L; Zeng X; Ben-David Y; Pan W
Eur J Med Chem; 2018 Jan; 143():1968-1980. PubMed ID: 29133049
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives as Potential Anti-Cancer Agents.
Hu SC; Yang J; Chen C; Song JR; Pan WD
Molecules; 2020 Apr; 25(7):. PubMed ID: 32283819
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives.
Liu Y; Xia B; Lan J; Hu S; Huang L; Chen C; Zeng X; Lou H; Lin C; Pan W
Molecules; 2017 Nov; 22(11):. PubMed ID: 29117113
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 5-Alkynyltetrandrine Derivatives and Evaluation of their Anticancer Activity on A549 Cell Lines.
Niu N; Qu T; Xu J; Lu X; Bodwell GJ; Zhao Z
Anticancer Agents Med Chem; 2019; 19(12):1454-1462. PubMed ID: 30961510
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
11. Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mTOR pathway.
Ling J; Li X; Wang M; Zhang C; Liu Y; Zhang X; Liu C; Ren Q; Zeng Y; Wang C; Chen Y; Sun C; Chen H; Zuo Y; Cao X; Deng Y; Ren B; Li D; Lu J
Bioorg Chem; 2024 Feb; 143():107069. PubMed ID: 38160477
[TBL] [Abstract][Full Text] [Related]
12. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots.
Chan EWC; Wong SK; Chan HT
J Integr Med; 2021 Jul; 19(4):311-316. PubMed ID: 33583757
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.
Ng LT; Chiang LC; Lin YT; Lin CC
Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745
[TBL] [Abstract][Full Text] [Related]
14. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
15. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of new tetrandrine derivatives and their antitumor activities.
Wei X; Qu TL; Yang YF; Xu JF; Li XW; Zhao ZB; Guo YW
J Asian Nat Prod Res; 2016 Oct; 18(10):966-75. PubMed ID: 27244089
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells.
Sun YF; Wink M
Phytomedicine; 2014; 21(8-9):1110-9. PubMed ID: 24856768
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma.
Lan J; Wang N; Huang L; Liu Y; Ma X; Lou H; Chen C; Feng Y; Pan W
Eur J Med Chem; 2017 Feb; 127():554-566. PubMed ID: 28109948
[TBL] [Abstract][Full Text] [Related]
19. Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.
Wu Z; Wang G; Xu S; Li Y; Tian Y; Niu H; Yuan F; Zhou F; Hao Z; Zheng Y; Li Q; Wang J
Tumour Biol; 2014 Mar; 35(3):2205-10. PubMed ID: 24185966
[TBL] [Abstract][Full Text] [Related]
20. Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.
Tian F; Ding D; Li D
Int J Oncol; 2015; 46(6):2355-63. PubMed ID: 25872479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
